Cargando…
Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.
The differential diagnosis of mesothelioma, primary adenocarcinomas and pleural metastases frequently causes problems. We have used the comparative genomic hybridization (CGH) technique on 34 malignant mesotheliomas and 30 primary lung carcinomas (adenocarcinoma, including bronchoalveolar carcinoma...
Autores principales: | Björkqvist, A. M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S., Mattson, K., Knuutila, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151225/ https://www.ncbi.nlm.nih.gov/pubmed/9460997 |
Ejemplares similares
-
Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.
por: Björkqvist, A. M., et al.
Publicado: (1997) -
Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis
por: Björkqvist, A-M, et al.
Publicado: (1999) -
Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
por: Tiainen, M., et al.
Publicado: (1989) -
High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma
por: Halme, M, et al.
Publicado: (1999) -
CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
por: Kettunen, Eeva, et al.
Publicado: (2019)